What’s Next in Brain Health? Lifestyle Interventions, Says One Expert
May 11, 2022

Henry Mahncke, PhD, explains why lifestyle interventions, such as diet and exercise, could be prescribed down the line to improve brain health.

Intranasal Insulin Could Help Slow Age-related Cognitive Decline, Suggests a New Study
May 03, 2022

Treatment with intranasal insulin improved executive function and verbal memory, as well as other measures, in participants with and without type 2 diabetes.

"Migraine is a Tremendously Rewarding Disease to Treat"
April 22, 2022

Yale headache specialist Christopher Gottschalk, MD, talks about the opportunities to make a marked difference in the quality of patients' lives.

Primary Care is the Answer to the Migraine Care Gap, Says Headache Specialist
April 12, 2022

US patients diagnosed with migraine: 40 million. US headache specialists: 600. Primary care is the answer, according to Christopher Gottschalk, MD.

Gepants for Migraine Prevention: A Perfect Fit for Primary Care
March 30, 2022

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with headache specialist Peter McAllister, MD.

Migraine Medicine Transformed: Christopher Gottschalk, MD Discusses How We Got to CGRP Inhibition
March 28, 2022

Gottschalk says CGRP inhibitors have made "...a life-changing transformation in how we think about and the kind of expectations we set for migraine treatment."

Before Migraine Was a Disease: Headache Expert Christopher Gottschalk, MD, Remembers his Roots
March 25, 2022

Christopher Gottschalk, MD, a leader in migraine research and clinical care, talks about what drew him to headache medicine early on and what it used to be like.

Even Modest Alcohol Consumption Found Linked to Decreases in Brain Volume
March 11, 2022

Increasing alcohol intake from 1 to 2 drinks per day was associated with brain changes equivalent to aging 2 years, according to a study of more than 36 000.

Atogepant: Pivotal Phase 3 Study Meets Primary Endpoint for Preventive Treatment of Chronic Migraine
March 10, 2022

Findings for atogepant from the phase 3 PROGRESS study will form the basis of a submission by AbbVie to FDA for a label expansion in the US.

Migraine Management Pearls for Primary Care with Neurologist Jessica Ailani, MD
March 10, 2022

Consider migraine screening for all women aged 20 to 50 years, suggests Ailani; you'll likely find a majority of them have migraine. More pearls follow.